These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 2822825)

  • 1. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
    Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
    J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
    Kazmierowski JA; Gallin JI; Reynolds HY
    J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
    Desai U; Dickey B; Varani J; Kreutzer DL
    J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of chemotactic factors in the pathogenesis of sarcoid granuloma formation].
    Ohdama S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Mar; 28(3):457-64. PubMed ID: 2214385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of complement activation in the pathogenesis of hypersensitivity pneumonitis: sequential changes of complement components and chemotactic activities in bronchoalveolar lavage fluids.
    Yoshizawa Y; Nomura A; Ohdama S; Tanaka M; Morinari H; Hasegawa S
    Int Arch Allergy Appl Immunol; 1988; 87(4):417-23. PubMed ID: 2852642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
    Teran LM; Campos MG; Begishvilli BT; Schröder JM; Djukanovic R; Shute JK; Church MK; Holgate ST; Davies DE
    Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of alveolar macrophage leukotriene B4 released by complement component C5.
    Robbins RA; Gossman GL; Allington LA; Kendall TJ; Stull TW; Rennard SI
    J Lab Clin Med; 1990 Apr; 115(4):497-503. PubMed ID: 2157785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
    Martin TR; Raugi G; Merritt TL; Henderson WR
    J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease.
    Standiford TJ; Rolfe MW; Kunkel SL; Lynch JP; Burdick MD; Gilbert AR; Orringer MB; Whyte RI; Strieter RM
    J Immunol; 1993 Sep; 151(5):2852-63. PubMed ID: 8360496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil chemotactic factors in bacterial pneumonia.
    Hopkins H; Stull T; Von Essen SG; Robbins RA; Rennard SI
    Chest; 1989 May; 95(5):1021-7. PubMed ID: 2539955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
    Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
    Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
    Ozaki T; Hayashi H; Tani K; Ogushi F; Yasuoka S; Ogura T
    Am Rev Respir Dis; 1992 Jan; 145(1):85-91. PubMed ID: 1309969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors.
    Wieslander E; Linden M; Håkansson L; Eklund A; Blaschke E; Brattsand R; Venge P
    Eur J Respir Dis; 1987 Oct; 71(4):263-72. PubMed ID: 2826202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human alveolar macrophages release a factor that inhibits phagocyte function.
    Sibille Y; Merrill WW; Naegel GP; Care SB; Cooper JA; Reynolds HY
    Am J Respir Cell Mol Biol; 1989 Nov; 1(5):407-16. PubMed ID: 2561589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
    Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
    J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the broncho-alveolar lavage fluid in smokers and patients with chronic obstructive lung disease.
    Terpstra GK; Wassink GA; Huidekoper HJ
    Int J Clin Pharmacol Res; 1987; 7(5):357-61. PubMed ID: 3312045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
    Losa García JE; Rodríguez FM; Martín de Cabo MR; García Salgado MJ; Losada JP; Villarón LG; López AJ; Arellano JL
    Mediators Inflamm; 1999; 8(1):43-51. PubMed ID: 10704089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.